Table 1.

Patient Characteristics

Characteristics	CRC (N=32)	GC (N=38)	OC (N=32)
Age (years)
Median	57	59	55
Range	29–79	39–80	37–75
Gender, n(%)
Male	19(59.4)	24(63.2)	0(0)
Female	13(40.6)	14(36.8)	32(100.0)
Performance status
(ECOG), n(%)
1	7(21.8)	13(34.2)	12(37.5)
2	15(46.9)	21(55.3)	16(50.0)
3	10(31.3)	4(10.5)	4(12.5)
Tumor histology, n(%)
Adenocarcinoma	32(100.0)	38(100.0)	－
Serous	－	－	22(81.3)
Mucinous	－	－	10(18.7)
Tumor site, n(%)
Right	17(53.1)	－	－
Left	15(46.9)	－	－
Tumor stage (TNM), n(%)
III	11(34.4)	12(31.6)	16(50.0)
IV	21(65.6)	26(68.4)	16(50.0)
Histologic differentiation
Well	5(15.6)	4(10.6)	4(12.5)
Moderate	17(53.1)	17(44.7)	18(56.3)
Poor	10(31.3)	17(44.7)	10(31.2)
Peritoneal metastasis, n(%)
Positive	18(56.3)	22(57.9)	18(56.3)
Negative	14(43.7)	16(42.1)	14(43.7)
Liver metastasis, n(%)
Positive	16(50.0)	17(44.7)	7(21.9)
Negative	16(50.0)	21(55.3)	25(78.1)
Ascites volume, n(%)
1500–3000mL	13(40.6)	19(50.0)	14(43.8)
over 3000 mL	19(59.4)	19(50.0)	18(56.2)
Diagnosis method of PC(N=58), n(%)
Pathological diagnosis	5(27.8)	8(36.4)	7(38.9)
CT and tumor cell in ascites	9(50.0)	14(63.6)	6(33.3)
MRI and tumor cell in ascites	4(22.2)	0(0)	5(27.8)
Gilly PC (N=58), n(%)
1	6(33.3)	4(18.2)	2(11.1)
2	4(22.2)	4(18.2)	4(22.2)
3	7(38.9)	10(45.4)	7(38.9)
4	1(5.6)	4(18.2)	5(27.8)
Treatment received
Prior chemotherapy, n(%)
Yes	16(50.0)	24(63.2)	11(34.4)
No	16(50.0)	14(36.8)	21(65.6)
Prior surgery, n(%)
Yes	15(46.9)	26(68.4)	12(37.5)
No	17(53.1)	12(31.6)	20(62.5)

Abbreviations: CRC, colorectal cancer; GC, gastric cancer; OC, ovarian cancer.